- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Triple-Negative Breast Carcinoma
Total 2484 results
-
National Cancer Center, KoreaActive, not recruitingTriple Negative Breast CancerKorea, Republic of
-
ImmunityBio, Inc.Active, not recruiting
-
Novartis PharmaceuticalsWithdrawn
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedTriple Negative Breast CancerUnited States
-
West German Study GroupCelgeneActive, not recruiting
-
PharmAbcineActive, not recruitingTriple Negative Breast CancerAustralia
-
Canadian Cancer Trials GroupUniversity Health Network, Toronto; AstraZenecaActive, not recruitingBreast CancerCanada
-
Fudan UniversityCompleted
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingBreast CancerNetherlands
-
Georgetown UniversityBristol-Myers SquibbActive, not recruitingTriple Negative Breast CancerUnited States
-
University of Wisconsin, MadisonThe V Foundation for Cancer ResearchTerminatedTriple Negative Breast CancerUnited States
-
Abbisko Therapeutics Co, LtdEnrolling by invitationTriple Negative Breast CancerChina
-
Baylor Research InstituteCompletedTriple Negative Breast CancerUnited States
-
The Methodist Hospital Research InstituteBristol-Myers SquibbCompleted
-
Cedars-Sinai Medical CenterAstraZenecaWithdrawnBreast Cancer | Triple Negative Breast CancerUnited States
-
University of Wisconsin, MadisonAvon FoundationTerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
ImmunityBio, Inc.Withdrawn
-
Cancer Institute and Hospital, Chinese Academy...Completed
-
Sun Yat-sen UniversityTerminatedTriple Negative Breast CancerChina
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Susan G. Komen Breast Cancer...CompletedBreast CancerUnited States
-
AZ-VUBUniversitaire Ziekenhuizen KU Leuven; Universitair Ziekenhuis BrusselCompleted
-
Massachusetts General HospitalNational Cancer Institute (NCI); Federal Share CoreWithdrawnBreast CancerUnited States
-
Ottawa Hospital Research InstituteCompleted
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
PfizerAstellas Pharma Inc; Medivation, Inc.Withdrawn
-
Genentech, Inc.SOLTI Breast Cancer Research GroupCompletedBreast CancerUnited States, Spain, Portugal
-
Mario Negri Institute for Pharmacological ResearchTerminatedTriple Negative Breast CancerSpain, Italy, Portugal
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, United Kingdom, France, United States, Denmark, Hong Kong
-
Instituto Nacional de Cancer, BrazilCompletedTriple Negative Breast Cancer | Triple Negative Breast NeoplasmsBrazil
-
Clinica Universidad de Navarra, Universidad de...Unknown
-
CASI Pharmaceuticals, Inc.University of Colorado, Denver; Indiana University Melvin and Bren Simon Cancer...CompletedTriple Negative Breast CancerUnited States, China
-
China Breast Cancer Clinical Study GroupUnknown
-
SanofiBreast Cancer Research FoundationCompletedTriple Negative Breast CancerUnited States
-
Russian Academy of Medical SciencesRussian Society of Clinical OncologyUnknownTriple Negative Breast Cancer
-
Fudan UniversityUnknown
-
Thomas Jefferson UniversityUnknownBreast CancerUnited States
-
Nippon Kayaku Co., Ltd.CompletedTriple Negative Breast CancerUnited States
-
Severance HospitalUnknown
-
Baylor Breast Care CenterM.D. Anderson Cancer CenterTerminatedBreast CancerUnited States
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH)Withdrawn
-
Tongji HospitalRecruitingBreast Cancer | TNBC - Triple-Negative Breast Cancer | Estrogen-receptor-negative Breast CancerChina
-
Institute of Cancer Research, United KingdomCase45 LtdNot yet recruitingTriple Negative Breast Cancer
-
UNICANCERNational Cancer Institute, FranceActive, not recruitingTriple-Negative Breast NeoplasmFrance
-
Genexine, Inc.Merck Sharp & Dohme LLCCompletedTriple Negative Breast CancerKorea, Republic of
-
Columbia UniversityWyeth is now a wholly owned subsidiary of Pfizer; Genentech, Inc.CompletedTriple Negative Breast CancerUnited States
-
Washington University School of MedicineTerminatedNeoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast CancerBreast NeoplasmsUnited States
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
PfizerCompletedNeoplasmUnited States, Spain, Canada, Italy, United Kingdom
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingTriple Negative Breast Cancer | Invasive Breast Cancer | Stage IV Breast Cancer | HER2 NegativeUnited States